Paul, who announced plans this week to seek re-election to the Senate in 2016 and is actively exploring whether to run for president, said he "wasn't a choir boy" when asked by Louisville television station WHAS if he had used…
National Football League teams were hit with surprise federal inspections on Sunday as part of an ongoing investigation of prescription drug abuse, tied to a lawsuit brought by former players. Jeffrey Brown talks to Sally Jenkins of The Washington Post,…
By Rialda Zukic
The Centers for Disease Control and Prevention reported on Friday that heroin-related overdoses more than doubled from 2010 to 2012.
Preclinical scientific research is done primarily on male subjects. This inequality obscures results and can be dangerous for women, who experience both illness and treatment differently than men.
By Mike Sherry, The Hale Center for Journalism
If you were dying and had exhausted all conventional treatment options, wouldn’t you want immediate access to a drug that might prove to be a miracle cure? That’s the promise of proposed legislation that could make Missouri the third state…
By Jordan Vesey
The supply and demand for heroin along the East Coast has skyrocketed in recent years with New York City once again at the center of a sophisticated nationwide distribution network.
Terminally ill patients often are frustrated to hear about experimental drugs they think might help them, but have not yet been approved by the Food and Drug Administration -- a process that often takes years.
By Alicia A. Caldwell, Associated Press
The Drug Enforcement Administration on Wednesday broadened its national crackdown on synthetic drug manufacturers, wholesalers and retailers as federal agents served hundreds of search and arrest warrants in at least 25 states.
By Associated Press
In a video statement Monday, Attorney General Eric Holder said the change is designed to help federal drug offenders imprisoned under now out-of-date sentencing guidelines.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.